Grants and support to enhance patient health

Boehringer Ingelheim is committed to enhancing patient care, and supporting the educational development of Healthcare Professionals in the UK, by providing support through:

  • Financial grants to Healthcare and Patient Organisations
  • Medical and educational goods and services (MEGS) to Healthcare Organisations
  • Educational meetings organised by Healthcare Organisations where Boehringer Ingelheim is not purchasing a commercial opportunity such as a promotional stand
Boehringer Ingelheim UK does not support:
  • Grants to individual Healthcare Professionals, including requests for funding of development opportunities, individual research projects or degree courses (e.g. MSc, PhD)
  • Sponsorship requests from Healthcare Professionals for attendance at professional and scientific conferences
  • Purchase of equipment
  • Religious programmes
  • Funding to Political Parties, i.e. the provision of financial contribution to a political party
  • Charitable fundraising events outside the UK
  • Social events.

At the current time Boehringer Ingelheim is only able to consider requests in the following therapy areas:

  • Interstitial lung disease
  • Oncology

Applying for grants and other forms of support

Grants, and other forms of support such as Medical and Educational Goods and Services (MEGS) must enhance patient care, or benefit the NHS and maintain patient care. Applications will only be accepted on behalf of Healthcare Organisations, not individual Healthcare Professionals. Transfers of Value will be publicly disclosed.

Consideration of each application will include a review of the history of prior or current MEGS sponsorship, and regrettably support will not be approved for:

  • Activities which have already commenced
  • Activities which are due to start within eight weeks of application submission
  • Grants to cover routine operational costs of the beneficiary institution
  • Provision of equipment
  • Personal development 

Please use this form to request support from Boehringer Ingelheim.

Please note

Every application will be reviewed and, where suitable, approved by a Boehringer Ingelheim non-commercial committee, on a first come/first served basis and subject to available funds. No commitment can be formally made prior to the grant of such approval by such committee. A written notification of rejection or approval of the request will be sent by Boehringer Ingelheim to the contact person named on the request form, within a maximum of six weeks from application. Any decision by the Committee is final and not subject to review. The online form accessible from this page is not intended to be used to request Boehringer Ingelheim support towards clinical research or joint working.  For these types of request please refer to your Boehringer Ingelheim contact. The provision of funding by Boehringer Ingelheim is by no means intended to induce or influence the prescription, administration, recommendation, purchase or sale of any Boehringer Ingelheim medicines.

Your privacy

We will keep a record of your name, email address, organisation address and other relevant information that you provide only for as long as required to process your application and meet financial, legal and transparency obligations. We will use data this for the purpose of evaluating your application and, if successful, processing and managing the application. You have rights to access your data.  For more information on these rights and how we process personal data, please see our Privacy Policy. Thank you.

UK/GEN-181098b | July 2018